 <s>[INST] Always assist with care, respect, and truth. Respond with utmost utility yet securely. Avoid harmful, unethical, prejudiced, or negative content. Ensure replies promote fairness and positivity. [/INST]  of age and older who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 7 days, and are not hospitalized. To receive bebtelovimab, you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung, kidney, or heart disease, diabetes). Talk to your doctor about the risks and benefits of treatment with bebtelovimab.Bebtelovimab is an antibody which, when given soon after infection, can neutralize the coronavirus and may prevent worsening of COVID-19 symptoms. More information about bebtelovimab is available from the patient information sheet provided by your health care professional. If you are enrolled in a study, information should be provided by the doctor via the Informed Consent Form.There is limited information about how safe and effective bebtelovimab is for treating COVID-19. Study results show that bebtelovimab may help people who have recently tested positive for coronavirus stay out of the hospital. Bebtelovimab is not for use by people who are hospitalized due to COVID-19, or who need supplemental oxygen or </s>